secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXELIXIS, INC. (EXEL)
CIK:        0000939767
Form:       8-K
Filed at:   2023-08-23T23:59:59+00:00
Accession:  0000939767-23-000093
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Exelixis CMO Vicki Goodman departs effective August 23, 2023; entitled to severance benefits
--------------------------------------------------------------------------------

- Vicki L. Goodman, EVP Product Development & Medical Affairs and CMO, concludes service effective August 23, 2023.
- Goodman is eligible for payments under Exelixis' Change in Control and Severance Benefit Plan.
- No successor or interim CMO has been named in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/939767/000093976723000093/0000939767-23-000093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/939767/000093976723000093/exel-20230823.htm
  HTML page:      https://secwatch.observer/filing/0000939767-23-000093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer